Blood and Lymphatic Cancer: Targets and Therapy
Dove Medical Press · United Kingdom
✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journal’s page ↗The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Source: Clarivate Journal Citation Reports.
Aims & Scope
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Web of Science Categories
Research Topics (OpenAlex)
Frequently asked questions about Blood and Lymphatic Cancer: Targets and Therapy
Is Blood and Lymphatic Cancer: Targets and Therapy a predatory journal?
PubScope has no integrity flags on record for Blood and Lymphatic Cancer: Targets and Therapy: it is indexed in Web of Science, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Blood and Lymphatic Cancer: Targets and Therapy?
Blood and Lymphatic Cancer: Targets and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date.
Is Blood and Lymphatic Cancer: Targets and Therapy indexed in Scopus and Web of Science?
Blood and Lymphatic Cancer: Targets and Therapy is indexed in Web of Science, DOAJ.
What is the aims and scope of Blood and Lymphatic Cancer: Targets and Therapy?
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref